Pluripotent stem cells made from pancreatic cancer cells are first human model of the cancer's progression, Penn study finds
Scientists from the Perelman School of Medicine at the University of Pennsylvania (home to the Abramson Cancer Center) have used stem-cell technology to create a research cell line from a patient with advanced pancreatic ductal adenocarcinoma (PDAC). This first-of-its-kind human-cell model of pancreatic cancer progression was published in Cell Reports.
Among the research institutions NCI funds across the United States, it currently designates 67 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.